Gestational Hypertension and Preeclampsia : ACOG Practice Bulletin, Number 222

Hypertensive disorders of pregnancy constitute one of the leading causes of maternal and perinatal mortality worldwide. It has been estimated that preeclampsia complicates 2-8% of pregnancies globally (). In Latin America and the Caribbean, hypertensive disorders are responsible for almost 26% of maternal deaths, whereas in Africa and Asia they contribute to 9% of deaths. Although maternal mortality is much lower in high-income countries than in developing countries, 16% of maternal deaths can be attributed to hypertensive disorders (). In the United States, the rate of preeclampsia increased by 25% between 1987 and 2004 (). Moreover, in comparison with women giving birth in 1980, those giving birth in 2003 were at 6.7-fold increased risk of severe preeclampsia (). This complication is costly: one study reported that in 2012 in the United States, the estimated cost of preeclampsia within the first 12 months of delivery was $2.18 billion ($1.03 billion for women and $1.15 billion for infants), which was disproportionately borne by premature births (). This Practice Bulletin will provide guidelines for the diagnosis and management of gestational hypertension and preeclampsia.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:135

Enthalten in:

Obstetrics and gynecology - 135(2020), 6 vom: 01. Juni, Seite e237-e260

Sprache:

Englisch

Links:

Volltext

Themen:

Journal Article
Practice Guideline

Anmerkungen:

Date Completed 25.11.2020

Date Revised 24.01.2021

published: Print

Citation Status MEDLINE

doi:

10.1097/AOG.0000000000003891

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM310253144